Cancer Biology & Genetics Program

The Luis Parada Lab

Research

Luis Parada
Luis F. Parada, PhD
Director, Brain Tumor Center; Albert C. Foster Chair; American Cancer Society Research Professor; Professor, Cell and Developmental Biology Program, Weill Cornell Graduate School of Medical Sciences

The Parada lab uses genetically engineered mouse models to recapitulate and study human disease. These mouse strains are used to understand the natural history of tumors of the nervous system, including glioblastoma multiforme (GBM), malignant peripheral nerve sheath tumors (MPNST), neurofibromas, and other diseases associated with neurofibromatosis (NF1). We seek to develop mouse cancer models based on concrete hypotheses and to rapidly transfer findings for validation in human cancer samples.

Research Projects

Publications Highlights

People

Luis Parada

Luis F. Parada, PhD

Director, Brain Tumor Center; Albert C. Foster Chair; American Cancer Society Research Professor; Professor, Cell and Developmental Biology Program, Weill Cornell Graduate School of Medical Sciences

  • Developmental biologist Luis F. Parada uses genetically engineered mouse models to study neurofibromatosis, brain tumors, cancer stem cells, and tumor progression.
  • PhD, Massachusetts Institute of Technology
Paradal@mskcc.org
Email Address

Members

Sheila Alcantara
Senior Research Scientist
Yu-Jung Chen, Graduate Student
Postdoctoral Fellow, Memorial Sloan Kettering Cancer Center, New York, NY
Computational Biologist II
Charlene Iltis
Research Associate
Swathi Iyer
Senior Research Scientist
Jing  Li, PhD
Senior Research Assistant
Michelle Lien
Senior Project Coordinator
Research Scholar
Alicia  Maria  Pedraza, MA
Senior Research Assistant
Senior Research Technician
Sameer Farouk Sait, Hematology-oncology Fellows at MSKCC/Cornell
Hematology-oncology Fellows at MSKCC/Cornell
Research Scholar
Research Associate
Tao Wang- Graduate Student
Graduate Student
Xuanhua Xie, PhD
Visiting Investigator
Mollie Chipman
Consultant, Boston Consulting Group, New York, NY
Dan Laks, PhD
Research Scholar
Yufeng  Shi, PhD
Research Associate
Daochun  Sun, PhD
Research Associate
Zilai  Wang, PhD
Research Associate

Achievements

  • Fellow, American Association for Cancer Research (AACR) Academy (2023)
  • Member, National Academy of Sciences (2011)
  • Fellow, American Association for the Advancement of Science (2009)
  • Member, National Academy of Medicine - Former Institute of Medicine (2007)
  • Member, American Academy of Arts and Sciences (2007)
  • The Academy of Medicine, Engineering and Sciences of Texas (TAMEST) (2007)
  • Member, Dana Alliance for Brain Initiatives (2003)
  • Professor, American Cancer Society Research (2002)

Open Positions

To learn more about available postdoctoral opportunities, please visit our Career Center

To learn more about compensation and benefits for postdoctoral researchers at MSK, please visit Resources for Postdocs

Career Opportunities

The Luis F. Parada laboratory currently has a position open for a postdoctoral research fellow.

Apply now

Get in Touch

Disclosures

Members of the MSK Community often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community. These activities outside of MSK further our mission, provide productive collaborations, and promote the practical application of scientific discoveries.

MSK requires doctors, faculty members, and leaders to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public. Not all disclosed interests and relationships present conflicts of interest. MSK reviews all disclosed interests and relationships to assess whether a conflict of interest exists and whether formal COI management is needed.

Luis F. Parada discloses the following relationships and financial interests:

  • Illumina
    Equity

The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.


This page and data include information for a specific MSK annual disclosure period (January 1, 2024 through disclosure submission in spring 2025). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at ecoi@mskcc.org.


View all disclosures